Beruflich Dokumente
Kultur Dokumente
( S E E
B E R T O N I
E T
A L . ,
P .
2 7 9 1 )
Diabetic Cardiomyopathy
Editorial
2950
13.
References
1. Rubler S, Dlugash J, Yuceoglu YZ, Kumral
T, Branwood AW, Grishman A: New type
of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol 30:
595602, 1972
2. Bell DSH: Diabetic cardiomyopathy: a
unique entity or a complication of coronary artery disease? Diabetes Care 18:708
714, 1995
3. Schannwell CM, Schneppenheim M, Perings S, Plehn G, Strauer BE: Left ventricular diastolic dysfunction as an early
manifestation of diabetic cardiomyopathy. Cardiology 98:3339, 2002
4. Di Bonito P, Cuomo S, Moio N, Sibilio G,
Sabatini D, Quattrin S, Capaldo B: Diastolic dysfunction in patients with noninsulin-dependent diabetes mellitus of
short duration. Diabet Med 13:321324,
1996
5. Beljic T, Miric M: Improved metabolic
control does not reverse left ventricular
filling abnormalities in newly diagnosed
non-insulin-dependent diabetes patients.
Acta Diabetol 31:147150, 1994
6. Nicolino A, Longobardi G, Furgi G, Rossi
M, Zoccolillo N, Ferrara N, Rengo F: Left
ventricular diastolic filling in diabetes
mellitus with and without hypertension.
Am J Hypertens 8:382389, 1995
7. Redfield MM, Jcobsen SJ, Burnett JC, Mahoney DW, Bailey KR, Rodeheffer RJ: Burden of systolic and diastolic ventricular
dysfunction in the community. JAMA
289:194 202, 2003
8. Poirier P, Bogaty P, Garneau C, Marois L,
Dumesnil JG: Diastolic dysfunction in
normotensive men with well-controlled
type 2 diabetes: importance of maneuvers
in echocardiographic screening for preclinical diabetic cardiomyopathy. Diabetes Care 24:510, 2001
9. Bertoni AG, Tsai A, Kasper EK, Francati
FL: Diabetes and idiopathic cardiomyopathy: a nationwide case-control study. Diabetes Care 26:27912795, 2003
10. Galderisi M, Anderson KM, Wilson PW,
Levy D: Echocardiographic evidence for
the existence of a distinct diabetic cardiomyopathy (the Framingham Heart
Study). Am J Cardiol 68:8589, 1991
11. Struthers AD, Morris AD: Screening for
and treating left-ventricular abnormalities
in diabetes mellitus: a new way of reducing cardiac deaths. Lancet 359:1430
1432, 2002
12. Phillips RA, Krakoff LR, Dunaif A, Fine-
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
good DT, Gorlin R, Shimabukuro S: Relation among left ventricular mass, insulin
resistance, and blood pressure in nonobese subjects. J Clin Endocrinol Metab 83:
4284 4288, 1998
Shehadeh A, Regan TJ: Cardiac consequences of diabetes mellitus. Clin Cardiol
18:301305, 1995
Devereux RB, Roman MJ, Paranicas M,
OGrady MJ, Lee ET, Welty TK, Fabsitz
RR, Robbins D, Rhoades ER, Howard BV:
Impact of diabetes on cardiac structure
and function: the Strong Heart Study. Circulation 101:22712276, 2000
Bauters C, Lamblin N, McFadden EP, Van
Bell E, Millaire A, DeGroote P: Influence
of diabetes mellitus on heart failure risk
and outcome. Cardiovasc Diabetol 2:116,
2003
Candido R, Forbes JM, Thomas MC, Thallas V, Dean RG, Burns WC, Tikellis C,
Ritchie RH, Twigg SM, Cooper ME, Burrell LM: A breaker of advanced glycation end products attenuates diabetesinduced myocardial structural changes.
Circ Res 92:785792, 2003
Ziegelhoffer A, Ravingerova T, Styk J, Sebokova J, Waczulikova I, Breier A, Dzurba
A, Volkovova K, Carsky J, Turecky L:
Mechanisms that may be involved in calcium tolerance of the diabetic heart. Mol
Cell Biochem 176:191198, 1997
Wakasaki H, Koya D, Schoen FJ, Jirousek
MR, Ways DK, Hoit BD, Walsh RA, King
GL: Targeted overexpression of protein
kinase C beta2 isoform in myocardium
causes cardiomyopathy. Proc Natl Acad Sci
U S A 94:9320 9325, 1997
Szabo C: PARP as a drug target for the
therapy of diabetic cardiovascular dysfunction. Drug News Perspect 15:197
205, 2002
Young ME, McNulty P, Taegtmeyer H:
Adaptation and maladaptation of the
heart in diabetes. Part II. Potential mechanisms. Circulation 105:18611870, 2002
Liu JE, Robbins DC, Palmieri V, Bella JN,
Roman MJ, Fabsitz R, Howard BV, Welty
TK, Lee ET, Devereux RB: Association of
albuminuria with systolic and diastolic
left ventricular dysfunction in type 2 diabetes: the Strong Heart Study. J Am Coll
Cardiol 42:20222028, 2003
Arnold JM, Yusuf S, Young J, Mathew J,
Johnstone D, Avezum A, Lonn E, Pogue J,
Bosch J, HOPE Investigators: Prevention
of heart failure in patients in the Heart
Outcome Prevention Evaluation (HOPE)
study. Circulation 107:1284 1290, 2003
Bell DSH: Use of beta blockers in patients
with diabetes. Endocrinologist 13:116
123, 2003
Nuttila P, Hallsten K, Kirsi A, Virtanen F,
Lonnqvst F, Vitcari J, Ronnemaa T, Knutti
J: Rosiglitazone but not metformin enhances insulin stimulated glucose uptake
Editorial
grani MP, Feldman AM, Francis GS, Ganiats TG, Goldstein S, Gregoratos G,
Jessup ML, Noble RJ, Packer M, Silver
MA, Stevenson LW, Gibbons RJ, Antman
EM, Alpert JS, Faxon DP, Fuster V, Jacobs
AK, Hiratzka LF, Russell RO, Smith SC Jr,
American College of Cardiology/American Heart Association: ACC/AHA guidelines for the evaluation and management
of chronic heart failure in the adult: executive summary: a report of the American
College of Cardiology/American Heart
Association Task Force on Practice
Guidelines (Committee to Revise 1995
Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Car-
2951